Form 8-K - Current report:
SEC Accession No. 0001559053-26-000009
Filing Date
2026-02-27
Accepted
2026-02-27 16:45:57
Documents
14
Period of Report
2026-02-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prta-20260227.htm   iXBRL 8-K 32638
2 EX-99.1 a2026febexx991sharerepurch.htm EX-99.1 10778
6 GRAPHIC - LOGO image_0a.jpg GRAPHIC 24834
  Complete submission text file 0001559053-26-000009.txt   203701

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20260227.xsd EX-101.SCH 1798
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20260227_lab.xml EX-101.LAB 23251
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20260227_pre.xml EX-101.PRE 13538
16 EXTRACTED XBRL INSTANCE DOCUMENT prta-20260227_htm.xml XML 2933
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35676 | Film No.: 26701062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)